Compare GLED & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLED | MIST |
|---|---|---|
| Founded | N/A | 2003 |
| Country | | Canada |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.0M | 146.9M |
| IPO Year | 2025 | 2019 |
| Metric | GLED | MIST |
|---|---|---|
| Price | $10.02 | $0.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 12.5K | ★ 1.7M |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.93 | $1.00 |
| 52 Week High | $10.06 | $3.06 |
| Indicator | GLED | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 40.59 |
| Support Level | $9.94 | $1.01 |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 44.44 | 16.67 |
GalaxyEdge Acquisition Corp is a newly organized blank check company. The company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.